217 related articles for article (PubMed ID: 30391941)
21. Pancreatic Dysfunction and Duodenal Inflammatory Responses Coordinate with Refractory Epigastric Pain Including Functional Dyspepsia: A Narrative Review.
Futagami S; Wakabayashi M
J Nippon Med Sch; 2022 Jun; 89(3):255-262. PubMed ID: 35082205
[TBL] [Abstract][Full Text] [Related]
22. Real-World, Non-Interventional, Observational Study to Evaluate Effectiveness and Tolerability of Acotiamide Hydrochloride Hydrate in Treatment of Functional Dyspepsia.
Porika SK; Veligandla KC; Muni SK; Acharya S; Mehta SC; Sharma AD
Adv Ther; 2018 Nov; 35(11):1884-1893. PubMed ID: 30350248
[TBL] [Abstract][Full Text] [Related]
23. Changes in patients' symptoms and gastric emptying after Helicobacter pylori treatment.
Zhang CL; Geng CH; Yang ZW; Li YL; Tong LQ; Gao P; Gao YQ
World J Gastroenterol; 2016 May; 22(18):4585-93. PubMed ID: 27182168
[TBL] [Abstract][Full Text] [Related]
24. Current and emerging therapeutic options for the management of functional dyspepsia.
Vandenberghe A; Schol J; Van den Houte K; Masuy I; Carbone F; Tack J
Expert Opin Pharmacother; 2020 Feb; 21(3):365-376. PubMed ID: 31899982
[No Abstract] [Full Text] [Related]
25. A long-term study of acotiamide in patients with functional dyspepsia: results from an open-label phase III trial in Japan on efficacy, safety and pattern of administration.
Matsueda K; Hongo M; Ushijima S; Akiho H
Digestion; 2011; 84(4):261-8. PubMed ID: 21934307
[TBL] [Abstract][Full Text] [Related]
26. Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying.
Futagami S; Shimpuku M; Song JM; Kodaka Y; Yamawaki H; Nagoya H; Shindo T; Kawagoe T; Horie A; Gudis K; Iwakiri K; Sakamoto C
Digestion; 2012; 86(2):114-21. PubMed ID: 22846371
[TBL] [Abstract][Full Text] [Related]
27. [Chronic pancreatitis: comparative assessment of effectiveness of dose-dependent therapy and prophylaxis of recurrence by polyenzyme drugs].
Butorova LI; Vasil'ev AP; Kozlov IM; Kuz'michev SB; Popova TN; Eletskaia AO; Egorycheva MP; Rassypnova LI
Eksp Klin Gastroenterol; 2007; (6):96-102. PubMed ID: 18416102
[No Abstract] [Full Text] [Related]
28. A double-blind placebo controlled study of acotiamide hydrochloride for efficacy on gastrointestinal motility of patients with functional dyspepsia.
Nakamura K; Tomita T; Oshima T; Asano H; Yamasaki T; Okugawa T; Kondo T; Kono T; Tozawa K; Ohda Y; Fukui H; Kazuhito F; Hirota S; Watari J; Miwa H
J Gastroenterol; 2017 May; 52(5):602-610. PubMed ID: 27639387
[TBL] [Abstract][Full Text] [Related]
29. Effects of acotiamide on functional dyspepsia patients with heartburn who failed proton pump inhibitor treatment in Japanese patients: A randomized, double-blind, placebo-controlled crossover study.
Funaki Y; Ogasawara N; Kawamura Y; Yoshimine T; Tamura Y; Izawa S; Ebi M; Sasaki M; Kasugai K
Neurogastroenterol Motil; 2020 Feb; 32(2):e13749. PubMed ID: 31612597
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography.
Kusunoki H; Haruma K; Manabe N; Imamura H; Kamada T; Shiotani A; Hata J; Sugioka H; Saito Y; Kato H; Tack J
Neurogastroenterol Motil; 2012 Jun; 24(6):540-5, e250-1. PubMed ID: 22385472
[TBL] [Abstract][Full Text] [Related]
31. Combination of high-density cholesterol level, elastic score, and severity of exocrine pancreatic dysfunction may be useful for a predictive factor for patients with early chronic pancreatitis.
Agawa S; Futagami S; Watanabe Y; Habiro M; Kawawa R; Yamawaki H; Tsushima R; Kirita K; Noda H; Akimoto T; Ueki N; Iwakiri K
J Gastroenterol Hepatol; 2023 Apr; 38(4):548-555. PubMed ID: 36399411
[TBL] [Abstract][Full Text] [Related]
32. Enzymatic therapy in patients with chronic pancreatitis.
Greenberger NJ
Gastroenterol Clin North Am; 1999 Sep; 28(3):687-93. PubMed ID: 10503144
[TBL] [Abstract][Full Text] [Related]
33. Acotiamide (Z-338) as a possible candidate for the treatment of functional dyspepsia.
Suzuki H; Hibi T
Neurogastroenterol Motil; 2010 Jun; 22(6):595-9. PubMed ID: 20553562
[TBL] [Abstract][Full Text] [Related]
34. [Efficiency of etiologic correction of concomitant ascaridosis in the complex treatment of chronic pancreatitis].
Babinets' LS; Droniak IuV; Pliashko KO; Babinets' AI
Lik Sprava; 2014 Nov; (11):116-8. PubMed ID: 25528847
[TBL] [Abstract][Full Text] [Related]
35. Endosonographic features in patients with non-alcoholic early chronic pancreatitis improved with treatment at one year follow up.
Higuchi K; Futagami S; Yamawaki H; Murakami M; Kirita K; Agawa S; Ikeda G; Noda H; Kodaka Y; Ueki N; Kaneko K; Gudis K; Ohashi R; Iwakiri K
J Clin Biochem Nutr; 2021 Jan; 68(1):86-94. PubMed ID: 33536717
[TBL] [Abstract][Full Text] [Related]
36. Adherence to an acotiamide therapeutic regimen improves long-term outcomes in patients with functional dyspepsia.
Shinozaki S; Osawa H; Sakamoto H; Hayashi Y; Miura Y; Lefor AK; Yamamoto H
J Gastrointestin Liver Dis; 2017 Dec; 26(4):345-350. PubMed ID: 29253047
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.
Xiao YL; Peng S; Tao J; Wang AJ; Lin JK; Hu PJ; Chen MH
Am J Gastroenterol; 2010 Dec; 105(12):2626-31. PubMed ID: 20823838
[TBL] [Abstract][Full Text] [Related]
38. Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia.
Tack J; Janssen P
Expert Opin Investig Drugs; 2011 May; 20(5):701-12. PubMed ID: 21417958
[TBL] [Abstract][Full Text] [Related]
39. Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan.
Iwakiri R; Tominaga K; Furuta K; Inamori M; Furuta T; Masuyama H; Kanke K; Nagahara A; Haruma K; Kinoshita Y; Higuchi K; Takahashi S; Kusano M; Iwakiri K; Kato M; Hongo M; Hiraishi H; Watanabe S; Miwa H; Naito Y; Fujimoto K; Arakawa T
Aliment Pharmacol Ther; 2013 Oct; 38(7):729-40. PubMed ID: 23957383
[TBL] [Abstract][Full Text] [Related]
40. Impact of sleep disorders in Japanese patients with functional dyspepsia (FD): nizatidine improves clinical symptoms, gastric emptying and sleep disorders in FD patients.
Futagami S; Yamawaki H; Izumi N; Shimpuku M; Kodaka Y; Wakabayashi T; Nagoya H; Shindo T; Kawagoe T; Gudis K; Itoh T; Sakamoto C
J Gastroenterol Hepatol; 2013 Aug; 28(8):1314-20. PubMed ID: 23611167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
